Independence Blue Cross announces investment in startup tackling affordability, outcomes, and experience with medications

Independence Blue Cross announced today that the company is investing in Evio, a new independent pharmacy solutions startup.

“Independence is investing in Evio because bold steps are needed to make accessing necessary, and in some cases life-saving, medications a simpler and more affordable experience. Evio builds upon our long-standing collaborations and innovative work with customers, health care providers and other important stakeholders in the prescription drug value chain to help members more easily access the medications they need, when and where they need them, at a cost they can afford.” – Gregory E. Deavens, Independence Blue Cross president and CEO

This venture adds to Independence’s suite of capabilities and is another example of the company’s investment in innovative solutions that provide value for members and customers. For more information about the announcement, click here.